Remimazolam

Records for this ingredient, by country (identity only).

ATC N05CD14 · 8 markets · 10 records

Remimazolam 8 markets · 10 records Forms
Filters

GB 2 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

  • 20 mg per mL / per unit basis not statedinjectionByfavo 20mg powder for solution for injection vials
  • 50 mg per mL / per unit basis not statedinjectionByfavo 50mg powder for concentrate for solution for injection vials

JP 2 records · 2 shown of 2 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 2.5 mg per mL / per unit basis not statedinjectionBYFAVO

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 20 mg per mL / per unit basis not statedinjectionBYFAVO 20 mg, poudre pour solution injectable

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.